Skip Navigation


Nucleic Acids Research Advance Access originally published online on April 13, 2009
Nucleic Acids Research 2009 37(11):3635-3644; doi:10.1093/nar/gkp217
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (3332K) Freely available
Right arrow Screen PDF (469K) Freely available
Right arrowOA All Versions of this Article:
37/11/3635    most recent
gkp217v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Lonkar, P.
Right arrow Articles by Glazer, P. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lonkar, P.
Right arrow Articles by Glazer, P. M.
Related Collections
Right arrow Mutagenesis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2009, Vol. 37, No. 11 3635-3644
© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Molecular Biology

Targeted correction of a thalassemia-associated β-globin mutation induced by pseudo-complementary peptide nucleic acids

Pallavi Lonkar1, Ki-Hyun Kim1, Jean Y. Kuan1, Joanna Y. Chin1, Faye A. Rogers1, Melissa P. Knauert1, Ryszard Kole2, Peter E. Nielsen3 and Peter M. Glazer1,*

1Department of Therapeutic Radiology and Department of Genetics, Yale University School of Medicine, P.O. Box 208040, New Haven, CT 06520-8040, 2Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599, USA and 3Department of Cellular and Molecular Medicine, University of Copenhagen, The Panum Institute, Blegdamsvej 3, Copenhagen, DK-2200, Denmark

*To whom correspondence should be addressed. Tel: +1 203 737 2788; Fax: +1 203 785 6309; Email: peter.glazer{at}yale.edu

Received March 6, 2008. Revised February 17, 2009. Accepted March 19, 2009.

β-Thalassemia is a genetic disorder caused by mutations in the β-globin gene. Triplex-forming oligonucleotides and triplex-forming peptide nucleic acids (PNAs) have been shown to stimulate recombination in mammalian cells via site-specific binding and creation of altered helical structures that provoke DNA repair. However, the use of these molecules for gene targeting requires homopurine tracts to facilitate triple helix formation. Alternatively, to achieve binding to mixed-sequence target sites for the induced gene correction, we have used pseudo-complementary PNAs (pcPNAs). Due to steric hindrance, pcPNAs are unable to form pcPNA–pcPNA duplexes but can bind to complementary DNA sequences via double duplex-invasion complexes. We demonstrate here that pcPNAs, when co-transfected with donor DNA fragments, can promote single base pair modification at the start of the second intron of the beta-globin gene. This was detected by the restoration of proper splicing of transcripts produced from a green fluorescent protein-beta globin fusion gene. We also demonstrate that pcPNAs are effective in stimulating recombination in human fibroblast cells in a manner dependent on the nucleotide excision repair factor, XPA. These results suggest that pcPNAs can be effective tools to induce heritable, site-specific modification of disease-related genes in human cells without purine sequence restriction.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.